INS and Glucose intolerance: In mouse models, supplementation with live A. muciniphila protected mice from glucose intolerance injury by modulating β-chenodeoxycholic acid (β-CDCA) levels, restoring insulin secretion, and enhancing fibroblast growth factor 15/19 (FGF15/19) expression, causing the subsequent stimulation of glycogen synthesis and inhibiting gluconeogenesis.